comments_image -

Spermicidal Breakfast Cereal

What would happen if contraceptive corn or antibiotic wheat accidentally made it to the supermarket? Nobody knows, but that isn't stopping agribusiness from pursuing these crops.
 
 
LIKE THIS ARTICLE ?
Join our mailing list:

Sign up to stay up to date on the latest headlines via email.

 
 
 
 

This article was translated from the Spanish by Miguel Alvarado.

Just when the global diatribe over food and genetically modified crops (GM) is heating up in tone and breadth, the corporations that create them are staging a showcase for a fresh batch of transgenics.

These new GM crops, known as biopharmaceuticals, or biopharms for short, produce industrial and pharmaceutical chemicals within their tissues. The plants, including soy, rice, corn and tobacco, are genetically altered to produce substances such as growth hormones, curdling agents (coagulants), vaccines for humans (as well as farm animals), human antibodies, industrial enzymes, contraceptives and even pregnancy deterrents.

Scientists and corporations alike embrace biopharmaceuticals with glee: "Imagine being able to harvest enough globulin (a compound that fights arthritis) for the whole world in all of fifty acres?" writes Dr. William O. Robertson for the Seattle Post-Intelligencer. "Imagine being able to find the protein healthy people use to prevent arthritis or breast cancer and being able to produce it in large quantities in rice and tobacco."

ProdiGene, a leader in the field, calculates that by the end of this decade, 10% of the corn produced in the US will be biopharmaceutical. The volume of biopharmaceutical drugs and chemicals could reach the $200 billion figure, according to Dow AgroSciences' Guy Cardinau.

Warnings

But some scientists and ecologists are concerned. Will it be possible to contain and segregate such crops, fruit and seed, in order to avoid a biological Chernobyl?

Is there any guarantee that these products won't accidentally end up at the supermarket? And how can we keep their pollen from fertilizing other fields and reproducing out of control?

"One single mistake from a biotechnology company and we'll be having someone else's prescription medicine for breakfast in our cereal," warns Larry Bohlen, spokesman for Friends of the Earth, an international ecology organization.

"What will happen if the pollen of a transgenic plant containing some kind of drug fertilizes a nearby edible crop?" argues the Erosion, Technology and Concentration Action Group (ETC) in a report published in 2000.

The report continues to ask: "How will the soil microorganisms and insects which benefit agriculture be affected by crops genetically designed to produce industrial and pharmaceutical chemicals? What will happen if animals eat the biopharmaceutical crops? Will the biopharmaceutical proteins be altered during the various stages of growth, harvest and storage? Will they cause allergic reactions?

According to biologist Brian Tokar, professor at the Institute for Social Ecology, the most serious problems concern cross-pollination and unknown effects to insects, soil microorganisms and other native life-forms.

A Little Mishap In Nebraska

There have been mistakes with these crops already. In November 2002, at an agricultural cooperative in Aurora, Nebraska, 500,000 bushels of soy were contaminated with biopharmaceutical corn. One of the coop members harvested an experimental batch of corn for ProdiGene the year before and then proceeded to plant a crop of soy for human consumption in the same field.

During a routine inspection, federal officials from the Department of Agriculture found the corn stalks for ProdiGene growing among the soy plants. By the time they made the discovery, soy from that field was already being stored mixed with the soy of other coop members. Fortunately, the authorities were able to segregate the contaminated grain just before it reached the supermarket aisles.

The company was slapped with a $500,000 fine for negligence; yet, and in spite of such gross near disaster, the government still allows the corporation to continue with biopharmaceutical research as well as keeping the precise nature of the contaminating batch in Nebraska a trade secret. Mark Ritchie, president of the Institute for Agriculture and Trade Policy, describes the incident as the "Three Mile Island" of biotechnology, in reference to the emergency caused by a nuclear reactor in the 70s.

submit to reddit

-
Email
Print
Share
LIKED THIS ARTICLE? JOIN OUR EMAIL LIST
Stay up to date with the latest AlterNet headlines via email
Advertisement
Most Read
Most Emailed
Most Discussed
On REDDIT
On DIGG
 
loading most read content ..
Advertisement
Thousands Protest Anti-Gay Pastor In North Carolina

By Annie-Rose Strasser | Think Progress

 
 
Bad Company for Mitt: Trump, Newt, and Now Meg Whitman

By Ed Kilgore | Washington Monthly

 
 
Battle of the Dems: Progressive Battles Blue Dog in Califorinia Congressional Race

By Adele M. Stan | AlterNet

 
 
Electoral Map Big Picture: If We Win This One, the GOP Fever Might Break

By BooMan | Booman Tribune

 
 
Pilot Kicks Sexist Passenger Off Her Plane

By Melissa Van Gelder | Ms. Magazine Blog

 
 
Koch Footing Bill for "Grassroots": Anti-Gov't Folks Have Billionaires Paying for Every Need

By Digby | Hullabaloo

 
 
Republican NLRB Member Accused of Leaks to Romney Campaign Resigns

By Laura Clawson | Daily Kos Labor

 
 
Record 45% of Iraq and Afghanistan Vets Have Filed for Disability

By Muriel Kane | Raw Story

 
 
President Obama's Memorial Day Address: "Honoring Those Who Made the Ultimate Sacrifice"

By Julianne Escobedo Shepherd | AlterNet

 
 
"Tubes": What the Internet is Made Of

By Laura Miller | Salon

 
 
 
 
 
loading ...
POWERED BY DIGG'S USERS
 
[ page served from web 2 ]